Alfason 0.1% Creme

Alfason is a established dermatological brand specializing in topical treatments for inflammatory skin conditions. The product shown, Alfason 0.1% Creme (containing hydrocortisone-17-butyrate), is widely utilized for treating eczemas and psoriasis.

Originally developed by the Danish pharmaceutical company LEO Pharma, which was founded in 1908, the brand has a long history of clinical application. In 2021, LEO Pharma sold a portfolio of established products, including Alfason, to the German pharmaceutical company Cheplapharm Arzneimittel GmbH.

Today, the brand is owned and distributed by Cheplapharm, which specializes in the acquisition and lifecycle management of legacy pharmaceutical brands from large pharma companies. While the brand has Danish roots, its current commercial home and primary manufacturing for the German market are centered in Germany.